Literature DB >> 27799534

SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.

Tomonari Muramatsu1,2, Chie Takemoto3,4, Yong-Tae Kim3, Hongfei Wang3, Wataru Nishii3,2, Takaho Terada3,2, Mikako Shirouzu3,4, Shigeyuki Yokoyama1,2.   

Abstract

The 3C-like protease (3CLpro) of severe acute respiratory syndrome coronavirus (SARS-CoV) cleaves 11 sites in the polyproteins, including its own N- and C-terminal autoprocessing sites, by recognizing P4-P1 and P1'. In this study, we determined the crystal structure of 3CLpro with the C-terminal prosequence and the catalytic-site C145A mutation, in which the enzyme binds the C-terminal prosequence of another molecule. Surprisingly, Phe at the P3' position [Phe(P3')] is snugly accommodated in the S3' pocket. Mutations of Phe(P3') impaired the C-terminal autoprocessing, but did not affect N-terminal autoprocessing. This difference was ascribed to the P2 residue, Phe(P2) and Leu(P2), in the C- and N-terminal sites, as follows. The S3' subsite is formed by Phe(P2)-induced conformational changes of 3CLpro and the direct involvement of Phe(P2) itself. In contrast, the N-terminal prosequence with Leu(P2) does not cause such conformational changes for the S3' subsite formation. In fact, the mutation of Phe(P2) to Leu in the C-terminal autoprocessing site abolishes the dependence on Phe(P3'). These mechanisms explain why Phe is required at the P3' position when the P2 position is occupied by Phe rather than Leu, which reveals a type of subsite cooperativity. Moreover, the peptide consisting of P4-P1 with Leu(P2) inhibits protease activity, whereas that with Phe(P2) exhibits a much smaller inhibitory effect, because Phe(P3') is missing. Thus, this subsite cooperativity likely exists to avoid the autoinhibition of the enzyme by its mature C-terminal sequence, and to retain the efficient C-terminal autoprocessing by the use of Phe(P2).

Entities:  

Keywords:  3CL protease; SARS; crystal structure; specificity; subsite cooperativity

Mesh:

Substances:

Year:  2016        PMID: 27799534      PMCID: PMC5135343          DOI: 10.1073/pnas.1601327113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  C-H...pi-interactions in proteins.

Authors:  M Brandl; M S Weiss; A Jabs; J Sühnel; R Hilgenfeld
Journal:  J Mol Biol       Date:  2001-03-16       Impact factor: 5.469

Review 2.  Subsite cooperativity in protease specificity.

Authors:  Natasha M Ng; Robert N Pike; Sarah E Boyd
Journal:  Biol Chem       Date:  2009 May-Jun       Impact factor: 3.915

3.  Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates.

Authors:  Aleksejs Kontijevskis; Ramona Petrovska; Sviatlana Yahorava; Jan Komorowski; Jarl E S Wikberg
Journal:  Bioorg Med Chem       Date:  2009-05-23       Impact factor: 3.641

4.  Detecting folding motifs and similarities in protein structures.

Authors:  G J Kleywegt; T A Jones
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

Review 6.  Activation and maturation of SARS-CoV main protease.

Authors:  Bin Xia; Xue Kang
Journal:  Protein Cell       Date:  2011-04-28       Impact factor: 14.870

7.  Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode.

Authors:  Shuai Chen; Felix Jonas; Can Shen; Rolf Hilgenfeld; Rolf Higenfeld
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

8.  Mechanism of the maturation process of SARS-CoV 3CL protease.

Authors:  Min-Feng Hsu; Chih-Jung Kuo; Kai-Ti Chang; Hui-Chuan Chang; Chia-Cheng Chou; Tzu-Ping Ko; Hui-Lin Shr; Gu-Gang Chang; Andrew H-J Wang; Po-Huang Liang
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

9.  Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure.

Authors:  Tiancen Hu; Yu Zhang; Lianwei Li; Kuifeng Wang; Shuai Chen; Jing Chen; Jianping Ding; Hualiang Jiang; Xu Shen
Journal:  Virology       Date:  2009-05-05       Impact factor: 3.616

10.  Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.

Authors:  Tomonari Muramatsu; Yong-Tae Kim; Wataru Nishii; Takaho Terada; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  FEBS J       Date:  2013-03-27       Impact factor: 5.542

View more
  83 in total

1.  Autocatalytic Processing and Substrate Specificity of Arabidopsis Chloroplast Glutamyl Peptidase.

Authors:  Nazmul H Bhuiyan; Elden Rowland; Giulia Friso; Lalit Ponnala; Elena J S Michel; Klaas J van Wijk
Journal:  Plant Physiol       Date:  2020-07-06       Impact factor: 8.340

2.  Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.

Authors:  Shangen Xu; Junwei Zhou; Yingjin Chen; Xue Tong; Zixin Wang; Jiahui Guo; Jiyao Chen; Liurong Fang; Dang Wang; Shaobo Xiao
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

3.  Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.

Authors:  Daman Reynolds; Michael Huesemann; Scott Edmundson; Amy Sims; Brett Hurst; Sherry Cady; Nathan Beirne; Jacob Freeman; Adam Berger; Song Gao
Journal:  Algal Res       Date:  2021-05-18       Impact factor: 4.401

4.  A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*.

Authors:  Kai S Yang; Xinyu R Ma; Yuying Ma; Yugendar R Alugubelli; Danielle A Scott; Erol C Vatansever; Aleksandra K Drelich; Banumathi Sankaran; Zhi Z Geng; Lauren R Blankenship; Hannah E Ward; Yan J Sheng; Jason C Hsu; Kaci C Kratch; Baoyu Zhao; Hamed S Hayatshahi; Jin Liu; Pingwei Li; Carol A Fierke; Chien-Te K Tseng; Shiqing Xu; Wenshe Ray Liu
Journal:  ChemMedChem       Date:  2020-12-10       Impact factor: 3.466

5.  Virtual screening on the web for drug repurposing: a primer.

Authors:  Yu Wai Chen; Chin-Pang Bennu Yiu; Kwok-Yin Wong
Journal:  J Biol Methods       Date:  2021-05-26

6.  Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.

Authors:  Kun Huang; Yufei Zhang; Xianfeng Hui; Ya Zhao; Wenxiao Gong; Ting Wang; Shaoran Zhang; Yong Yang; Fei Deng; Qiang Zhang; Xi Chen; Ying Yang; Xiaomei Sun; Huanchun Chen; Yizhi J Tao; Zhong Zou; Meilin Jin
Journal:  EBioMedicine       Date:  2021-05-13       Impact factor: 8.143

Review 7.  The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.

Authors:  Nicholas A Wong; Milton H Saier
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 6.208

8.  Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.

Authors:  Kemel Arafet; Natalia Serrano-Aparicio; Alessio Lodola; Adrian J Mulholland; Florenci V González; Katarzyna Świderek; Vicent Moliner
Journal:  Chem Sci       Date:  2020-11-27       Impact factor: 9.825

9.  Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.

Authors:  Juliana C Ferreira; Samar Fadl; Adrian J Villanueva; Wael M Rabeh
Journal:  Front Chem       Date:  2021-06-24       Impact factor: 5.221

10.  New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach.

Authors:  Henrique S Fernandes; Sérgio F Sousa; Nuno M F S A Cerqueira
Journal:  Mol Divers       Date:  2021-06-24       Impact factor: 3.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.